# A Safety Study Of A Single Vaginal Administration Of P2G12 Antibody In Healthy Female Subjects

> **NCT01403792** · PHASE1 · COMPLETED · sponsor: **University of Surrey** · enrollment: 11 (actual)

## Conditions studied

- Human Immunodeficiency Virus

## Interventions

- **DRUG:** P2G12

## Key facts

- **NCT ID:** NCT01403792
- **Lead sponsor:** University of Surrey
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2011-12-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01403792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01403792, "A Safety Study Of A Single Vaginal Administration Of P2G12 Antibody In Healthy Female Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01403792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*